[Retracted] Distinct Molecular Subtypes of Diffuse Large B Cell Lymphoma Patients Treated with Rituximab-CHOP Are Associated with Different Clinical Outcomes and Molecular Mechanisms

Figure 8

Subgroup survival analysis of the 10-gene signature for DLBCL. (a, b) Kaplan-Meier curves of overall and progression-free survival in the (a) GC and non-GC groups as well as (b) ABC and GCB subtypes.

(a)

(b)